EX-10.1 2 dex101.htm STRATEGIC ALLIANCE AGREEMENT BETWEEN REGISTRANT AND PURDUE PHARMACEUTICAL Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. EXECUTION VERSION STRATEGIC...Strategic Alliance Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 JurisdictionThis Strategic Alliance Agreement (the “Agreement”) is entered into as of the 19 th day of November 2008 (the “Effective Date”) by and between Infinity Pharmaceuticals, Inc., a Delaware corporation having its principal office at 780 Memorial Drive, Cambridge, Massachusetts 02139 (“Infinity”), and Purdue Pharmaceutical Products L.P., a Delaware limited partnership having its principal office at One Stamford Forum, 201 Tresser Boulevard, Stamford, Connecticut 06901-3431 (“Purdue”).
STRATEGIC ALLIANCE AGREEMENT BY AND BETWEEN INFINITY PHARMACEUTICALS, INC. AND PURDUE PHARMACEUTICAL PRODUCTS L.P.Strategic Alliance Agreement • March 13th, 2009 • Infinity Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 13th, 2009 Company Industry JurisdictionThis Strategic Alliance Agreement (the “Agreement”) is entered into as of the 19 th day of November 2008 (the “Effective Date”) by and between Infinity Pharmaceuticals, Inc., a Delaware corporation having its principal office at 780 Memorial Drive, Cambridge, Massachusetts 02139 (“Infinity”), and Purdue Pharmaceutical Products L.P., a Delaware limited partnership having its principal office at One Stamford Forum, 201 Tresser Boulevard, Stamford, Connecticut 06901-3431 (“Purdue”).